Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 195 results

] Title Type Year

Filters: First Letter Of Last Name is B [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

B

Busaidy, N. L., Farooki, A., Dowlati, A., Perentesis, J. P., Dancey, J. E., Doyle, L. A., et al.. (2012). Management of metabolic effects associated with anticancer agents targeting the PI3K-Akt-mTOR pathway. J Clin Oncol, 30(23), 2919-28. presented at the 2012 Aug 10. doi:10.1200/JCO.2011.39.7356

Busaidy, N. L., Farooki, A., Dowlati, A., Perentesis, J. P., Dancey, J. E., Doyle, L. A., et al.. (2012). Management of Metabolic Effects Associated with Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway. J Clin Oncol, 30, 2919-2928. presented at the 08/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22778315

Burks, A. W., Jones, S. M., Wood, R. A., Fleischer, D. M., Sicherer, S. H., Lindblad, R., et al.. (2012). Oral Immunotherapy for Treatment of Egg Allergy in Children. N Engl J Med, 367, 233-243. presented at the 07/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22808958

A Burks, W., Jones, S. M., Wood, R. A., Fleischer, D. M., Sicherer, S. H., Lindblad, R. W., et al.. (2012). Oral immunotherapy for treatment of egg allergy in children. N Engl J Med, 367(3), 233-43. presented at the 2012 Jul 19. doi:10.1056/NEJMoa1200435

A Burks, W., Wood, R. A., Jones, S. M., Sicherer, S. H., Fleischer, D. M., Scurlock, A. M., et al.. (2015). Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial. J Allergy Clin Immunol, 135(5), 1240-8.e1-3. presented at the 2015 May. doi:10.1016/j.jaci.2014.12.1917

Burks, A. W., Wood, R. A., Jones, S. M., Sicherer, S. H., Fleischer, D. M., Scurlock, A. M., et al.. (2015). Sublingual Immunotherapy for Peanut Allergy: Long-Term Follow-up of a Randomized Multicenter Trial. J Allergy Clin Immunol. presented at the 03/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25656999

Burke, G. W., Kaufman, D. B., Bruce, D. S., Sutherland, D., Johnson, C. P., Gaber, A. O., et al.. (2002). The Effect of Antibody Induction in Simultaneous Pancreas Kidney (SPK) Transplant Patients Receiving Tacrolimus (TAC) and Mycophenolate Mofetil (MMF): Two-Year Results. presented at the 2002.

Burke, G. W., Kauffman, D. B., Millis, J. B., Gaber, A. O., Johnson, C. P., Sutherland, D. E. R., et al.. (2004). A prospective, randomized, trial of the effect of multi-center trial of antibody induction in simultaneous pancreas and kidney transplantation: three year results. American Journal of Transplantation, 77, 1269-75. presented at the 2004.

Burke, G. W., Kaufman, D. B., Bruce, D. S., Sutherland, D., Johnson, C. P., Gaber, A. O., et al.. (2001). Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) +/- antibody induction in simultaneous pancreas kidney (SPK) transplantation: one year results. presented at the 2001.

Burke, G., Kaufman, D., Millis, J., Gaber, A. O., Johnson, C., Sutherland, D., et al.. (2003). The effect of antibody induction in simultaneous pancreas kidney (SPK) transplant patients receiving tacrolimus (TAC) and Mycophenolate Mofetil (MMF): Three-year results. presented at the 2003.

Burke, G. W., Kaufman, D. B., J Millis, M., A Gaber, O., Johnson, C. P., Sutherland, D. E. R., et al.. (2004). Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results. Transplantation, 77(8), 1269-75. presented at the 2004 Apr 27. doi:10.1097/01.tp.0000123903.12311.36

Burke, C., & Lindblad, A.. (2011). Experiences of the NINDS clinical research collaboration with the use of a virtual coordinator. In Annual Meeting of the Society for Clinical Trials. presented at the 15/05/2011, Vancouver, Canada. Retrieved from http://www.sctweb.org/public/meetings/2011/home.cfm

Bures, R., Gaitan, A., Zhu, T., Graziosi, C., McGrath, K. M., Tartaglia, J., et al.. (2000). Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses, 16(18), 2019-35. presented at the 2000 Dec 10. doi:10.1089/088922200750054756

Bures, R., Gaitan, A., Zhu, T., Graziosi, C., McGrath, K. M., Tartaglia, J., et al.. (2000). Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus Type 1. AIDS Res HumRetroviruses, 16, 2019-35. presented at the 2000.

Burch, J. W., Mair, D. C., Meny, G. M., Moroff, G., Ching, S. S. T., Naidoff, M. A., et al.. (2005). The risk of posterior subcapsular cataracts in granulocyte donors. Transfusion, 45(11), 1701-8. presented at the 2005 Nov. doi:10.1111/j.1537-2995.2005.00594.x

Burch, J., Mair, D., Meny, G., Moroff, G., Ching, S., Naidoff, M., et al.. (2005). The Risk of Posterior Subcapsular Cataracts in Granulocyte Donors. Transfusion, 45, 1701-1708. presented at the 11/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16271093

Bunyavanich, S., Shen, N., Grishin, A., Wood, R., Burks, W., Dawson, P., et al.. (2016). Early-life gut microbiome composition and milk allergy resolution. J Allergy Clin Immunol, 138(4), 1122-1130. presented at the 2016 10. doi:10.1016/j.jaci.2016.03.041

Buggage, R., Thompson, D., Sen, H., Al-Khatib, S., Srivastava, S., Ursea, R., et al.. (2003). A Study to investigate the Safety and Efficacy of Daclizumab to treat the ocular complications related to the Behcet’s disease. presented at the 2003.

Buggage, R. R., Levy-Clarke, G., Sen, H. N., Ursea, R., Srivastava, S. K., Suhler, E. B., et al.. (2007). A Double-Masked, Randomized Study to Investigate the Safety and Efficacy of Daclizumab to Treat the Ocular Complications Related to Behçet's Disease. Ocul Immunol Inflamm, 15, 63-70. presented at the 03-04/2007. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17558830

Buggage, R. R., Levy-Clarke, G., Sen, H. N., Ursea, R., Srivastava, S. K., Suhler, E. B., et al.. (2007). A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.. Ocul Immunol Inflamm, 15(2), 63-70. presented at the 2007 Mar-Apr. doi:10.1080/09273940701299370

Buggage, R., Thompson, D., Sen, H., Al-Khatib, S., Srivastava, S., Ursea, R., et al.. (2003). A masked randomized study to investigate the safety and efficacy of Daclizumab for treatment of Ocular Behcet’s Disease. presented at the 2003.

Bucuvalas, J. C., Zeng, L., & Anand, R.. (2004). Predictors of length of stay for pediatric liver transplant recipients. Liver Transpl, 10, 1011-7. presented at the 2004. Retrieved from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15390327

Bucuvalas, J. C., Zeng, L., & Anand, R.. (2004). Predictors of length of stay for pediatric liver transplant recipients. Liver Transpl, 10(8), 1011-7. presented at the 2004 Aug. doi:10.1002/lt.20203

Buckelew, S. P., Conway, M. D., Parker, J. C., Deuser, W. E., Jennings, J., Wity, T. E., et al.. (1998). Biofeedback/relaxation training and exercise intervention for fibromyalgia: A prospective trial. Arthritis Care and Research, 11, 196-209. presented at the 1998.

Buckelew, S. P., Conway, R., Parker, J., Deuser, W. E., Read, J., Witty, T. E., et al.. (1998). Biofeedback/relaxation training and exercise interventions for fibromyalgia: a prospective trial. Arthritis Care Res, 11(3), 196-209. presented at the 1998 Jun. doi:10.1002/art.1790110307

1
2
3
4
5
6
7
8
next
last